Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Centrillion Biosciences Announces Grant Recipients

Published: Friday, July 19, 2013
Last Updated: Friday, July 19, 2013
Bookmark and Share
Centrillion Biosciences has announced the winners of The Sequencing Innovation Grant Program.

The program was open to academic, clinical and industrial researchers and was awarded based on research proposals best demonstrating potential innovative applications of next generation sequencing technology to advancing human health care.

Two winning teams were chosen; Ryan Hernandez and Nicolas Strauli won for their proposal, “Intra-patient coevolution between HIV and the adaptive immune system.” Dr. Hernandez is an Assistant Professor in the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco. Nicolas Strauli is a graduate student working with Dr. Hernandez. Jianzhong Hu won for his proposal, “Association of Meconium Microbiome to Preterm Birth and Maternal Environment”. Dr. Hu is an Assistant Professor in the Department of Genetics and Genomic Sciences at Mount Sinai Medical Center in New York City, NY.

About the award, Dr. Hernandez said: "This award will enable us to create a remarkable dataset that will yield insights into the problem of HIV's evasion of the adaptive immune system. By using next-generation sequencing, we have the potential to detail all of the steps taken by HIV and our immune system during the evolutionary dance that they play over the course of long-term infections. “

About the impact this award will have on his work, Dr. Hu said, “…this award will allow us to determine the role of the microbiome in preterm birth. By also assessing the interaction between the microbiome and clinical and environmental factors, we may begin to detect microbial predictors affecting health in later childhood development.”

The awards include sample sequencing and bioinformatics analysis services.

"We were extremely pleased with the quality of proposals for applications of next-gen sequencing and genomics to important problems in human health,” said Wei Zhou, Centrillion’s President and CEO. “Choosing the winners was a difficult decision and we wish we could support all of the research proposals.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
A Boost for Regenerative Medicine
Growing tissues and organs in the lab for transplantation into patients could become easier after scientists discovered an effective way to produce three-dimensional networks of blood vessels, vital for tissue survival yet a current stumbling block in regenerative medicine.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
Nanoparticles Target, Transform Fat Tissue
Nanoparticles designed to target white fat and convert it to calorie-burning brown fat slowed weight gain in obese mice without affecting food intake. This proof-of-concept work could lead to new therapies to treat obesity.
New Cancer Fighters Emerge From Lab
Rice University lab simplifies total synthesis of anti-cancer agent.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!